Steven Cohen’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$476K Sell
123,557
-91,030
-42% -$332K ﹤0.01% 3194
2026
Q1
$848K Sell
214,587
-107,703
-33% -$543K ﹤0.01% 2861
2025
Q4
$2.18M Buy
+322,290
New +$2.26M ﹤0.01% 2429
2024
Q3
Sell
-5,800
Closed -$40.2K 2207
2024
Q2
$40.2K Buy
+5,800
New +$40.8K ﹤0.01% 1757
2023
Q4
Sell
-2,100
Closed -$15.3K 2545
2023
Q3
$15.3K Buy
+2,100
New +$15.6K ﹤0.01% 2307
2017
Q4
Sell
-100,000
Closed -$1.19M 1011
2017
Q3
$1.19M Buy
+100,000
New +$1.48M 0.01% 723
2016
Q3
Sell
-150,000
Closed -$1.2M 802
2016
Q2
$1.2M Buy
+150,000
New +$1.17M 0.01% 609
2016
Q1
Sell
-908,600
Closed -$8.51M 798
2015
Q4
$8.51M Buy
908,600
+85,700
+10% +$743K 0.07% 320
2015
Q3
$7.94M Sell
822,900
-11,400
-1% -$120K 0.06% 348
2015
Q2
$9.67M Sell
834,300
-108,200
-11% -$1.11M 0.07% 327
2015
Q1
$9.8M Buy
+942,500
New +$8.82M 0.07% 336
2014
Q4
Sell
-825,000
Closed -$5.88M 756
2014
Q3
$5.88M Sell
825,000
-81,800
-9% -$570K 0.04% 374
2014
Q2
$6.43M Buy
+906,800
New +$5.31M 0.04% 409

Other funds holding MDXG

Steven Cohen's MDXG Position: Q2 2026 in Review

Steven Cohen reduced its MiMedx Group (MDXG) stake by 42% in Q2 2026, selling an estimated $332K and leaving 123,557 shares worth $476K. The position accounts for ﹤0.01% of the portfolio, ranked #3194.

Steven Cohen first reported a position in MDXG in Q2 2014 and has held it in 13 quarters since. The position peaked at $9.8M in Q1 2015. 225 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Steven Cohen held 123,557 shares of MiMedx Group worth $476K as of Q2 2026.
  • Steven Cohen sold 91,030 MiMedx Group shares in Q2 2026, an estimated $332K.
  • MiMedx Group made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #3194 holding.
  • Steven Cohen first reported a position in MiMedx Group in Q2 2014 and has held it in 13 quarters since.
  • Steven Cohen's MiMedx Group position peaked at $9.8M in Q1 2015.
  • 225 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.